These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 31473027)
1. [Spironolactone in resistant essential hypertension]. Lorthioir A; Belmihoub I; Fouassier D; Azizi M; Amar L Presse Med; 2019 Dec; 48(12):1431-1438. PubMed ID: 31473027 [TBL] [Abstract][Full Text] [Related]
2. Management of resistant hypertension: expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology. Denolle T; Chamontin B; Doll G; Fauvel JP; Girerd X; Herpin D; Vaïsse B; Villeneuve F; Halimi JM J Hum Hypertens; 2016 Nov; 30(11):657-663. PubMed ID: 26818804 [TBL] [Abstract][Full Text] [Related]
3. [Management of resistant hypertension. Expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology]. Denolle T; Chamontin B; Doll G; Fauvel JP; Girerd X; Herpin D; Vaïsse B; Villeneuve F; Halimi JM Presse Med; 2014 Dec; 43(12 Pt 1):1325-31. PubMed ID: 25459067 [TBL] [Abstract][Full Text] [Related]
4. Management of resistant hypertension: aldosterone antagonists or intensification of diuretic therapy? Verdalles U; García de Vinuesa S; Goicoechea M; Macías N; Santos A; Perez de Jose A; Verde E; Yuste C; Luño J Nephrology (Carlton); 2015 Aug; 20(8):567-71. PubMed ID: 25818266 [TBL] [Abstract][Full Text] [Related]
5. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial. Cestário EDES; Fernandes LAB; Giollo-Júnior LT; Uyemura JRR; Matarucco CSS; Landim MIP; Cosenso-Martin LN; Tácito LHB; Moreno H; Vilela-Martin JF; Yugar-Toledo JC Trials; 2018 Feb; 19(1):101. PubMed ID: 29433578 [TBL] [Abstract][Full Text] [Related]
6. [What is resistant hypertension and how to diagnose it?]. Lorthioir A; Belmihoub I; Amar L; Azizi M Rev Prat; 2019 Dec; 69(10):1099-1103. PubMed ID: 32237581 [TBL] [Abstract][Full Text] [Related]
7. Treatment of Resistant and Refractory Hypertension. Acelajado MC; Hughes ZH; Oparil S; Calhoun DA Circ Res; 2019 Mar; 124(7):1061-1070. PubMed ID: 30920924 [TBL] [Abstract][Full Text] [Related]
8. Prevention And Treatment of Hypertension With Algorithm-based therapy (PATHWAY) number 2: protocol for a randomised crossover trial to determine optimal treatment for drug-resistant hypertension. Williams B; MacDonald TM; Caulfield M; Cruickshank JK; McInnes G; Sever P; Webb DJ; Salsbury J; Morant S; Ford I; Brown MJ BMJ Open; 2015 Aug; 5(8):e008951. PubMed ID: 26253568 [TBL] [Abstract][Full Text] [Related]
9. Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association. Carey RM; Calhoun DA; Bakris GL; Brook RD; Daugherty SL; Dennison-Himmelfarb CR; Egan BM; Flack JM; Gidding SS; Judd E; Lackland DT; Laffer CL; Newton-Cheh C; Smith SM; Taler SJ; Textor SC; Turan TN; White WB; Hypertension; 2018 Nov; 72(5):e53-e90. PubMed ID: 30354828 [TBL] [Abstract][Full Text] [Related]
10. Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial. Václavík J; Sedlák R; Plachy M; Navrátil K; Plásek J; Jarkovsky J; Václavík T; Husár R; Kociánová E; Táborsky M Hypertension; 2011 Jun; 57(6):1069-75. PubMed ID: 21536989 [TBL] [Abstract][Full Text] [Related]
11. The effect of spironolactone in patients with resistant arterial hypertension in relation to baseline blood pressure and secondary causes of hypertension. Vaclavik J; Sedlak R; Jarkovsky J; Kocianova E; Taborsky M Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Mar; 157(1):50-5. PubMed ID: 23128822 [TBL] [Abstract][Full Text] [Related]
12. Evaluation and pharmacologic approach to patients with resistant hypertension. Adams M; Bellone JM; Wright BM; Rutecki GW Postgrad Med; 2012 Jan; 124(1):74-82. PubMed ID: 22314117 [TBL] [Abstract][Full Text] [Related]
13. Controversies in Hypertension V: Resistant and Refractory Hypertension. Filippone EJ; Naccarelli GV; Foy AJ Am J Med; 2024 Jan; 137(1):12-22. PubMed ID: 37832756 [TBL] [Abstract][Full Text] [Related]
14. Addition of spironolactone in patients with resistant hypertension: A meta-analysis of randomized controlled trials. Liu L; Xu B; Ju Y Clin Exp Hypertens; 2017; 39(3):257-263. PubMed ID: 28448185 [TBL] [Abstract][Full Text] [Related]